Datroway
Payments companies reported to CMS as associated with Datroway. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Datroway, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Datroway
These are the largest totals companies reported as associated with Datroway. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hatim Husain | San Diego, CA | Internal Medicine | $90,567.94 |
| Maria Theodoulou | Albany, NY | Medical Oncology | $88,439.76 |
| Martin Dietrich | Rockledge, FL | Hematology & Oncology | $86,269.27 |
| Amit Patel | Jersey City, NJ | Hematology & Oncology | $75,138.98 |
| Kit Lu | Harrisburg, PA | Hematology & Oncology | $64,457.34 |
| Wassim Mchayleh | Altamonte Springs, FL | Hematology & Oncology | $64,372.90 |
| Ajay Kandra | Madison, IN | Hematology & Oncology | $59,381.64 |
| Mohammadbagher Ziari | Corona, CA | Hematology & Oncology | $58,056.97 |
| Kristi Orbaugh | Indianapolis, IN | Nurse Practitioner | $54,248.85 |
| Noam Drazin | Beverly Hills, CA | Medical Oncology | $53,248.62 |
Prescribed Datroway?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.